Although the intention to treat analysis was borderline non-significant in that trial, planned sub-analyses showed prolongation in gestation was significant among those who managed to take the trial medication, a 11.5 day prolongation.
1
—
—
Although the intention to treat analysis was borderline non-significant in that trial, planned sub-analyses showed prolongation in gestation was significant among those who managed to take the trial medication, a 11.5 day prolongation.